NeuralCipher Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
ABSTRACT Parkinson’s disease is a neurodegenerative disorder characterized by α-synuclein aggregation in neurons. Recent advances suggest α-synuclein aggregates could serve as a biomarker for Parkinson’s disease and related synucleinopathies. This study used surface-based fluorescence intensity distribution analysis (sFIDA) to measure α-synuclein aggregates in urine. Patients with Parkinson’s disease and isolated REM sleep behavior disorder, a precursor to Parkinson’s disease, had elevated concentrations compared to healthy controls. Sensitivity and specificity were 83% and 65% for Parkinson’s disease versus controls and 89% and 62% for isolated REM sleep behavior disorder versus controls. The findings highlight sFIDA’s potential for diagnosing synucleinopathies.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.